GlaxoSmithKline Consumer Healthcare strongly supports the Food and Drug Administration for holding a scientific workshop this week that focused on the risks and benefits associated with the long-term use of nicotine replacement therapy (NRT) products...
Ingen kommentarer:
Send en kommentar